For All The Latest Thailand Medical News, COVID-19 News, Long COVID News, H5N1 News, Research News, Health News, Hospital News, Herb News, HIV News, Cancer News, Diabetes News, Alzheimer News, Anti-Aging News, Mental Health News, etc

Source: Obesity  Oct 18, 2021  1 year, 11 months, 2 weeks, 1 day, 13 minutes ago

BREAKING! Japanese Researchers Discover That Lack Of A Brain Protein Called XRN1 Disrupts Appetite And Metabolic Regulation Resulting In Obesity!

BREAKING! Japanese Researchers Discover That Lack Of A Brain Protein Called XRN1 Disrupts Appetite And Metabolic Regulation Resulting In Obesity!
Source: Obesity  Oct 18, 2021  1 year, 11 months, 2 weeks, 1 day, 13 minutes ago
A new breakthrough study by researchers From Okinawa Institute of Science and Technology (OIST) Graduate University-Japan and the Institute of Medical Science at the University of Tokyo-Japan have identified a brain protein that plays a key in how the brain regulates appetite and metabolism.

The study team found that loss of the protein, XRN1, from the forebrain, resulted in obese mice with an insatiable appetite.
According to the study team, the control of mRNA stability and degradation is essential for appropriate gene expression, and its dysregulation causes various disorders, including cancer, neurodegenerative diseases, diabetes, and obesity.
It has been known that the 5′–3′ exoribonuclease XRN1 protein executes the last step of RNA decay, but its physiological impact is not well understood.
In order to understand its detailed mechanisms, forebrain-specific Xrn1 conditional knockout mice (Xrn1-cKO) were generated, as Xrn1 null mice were embryonic lethal. 
Interestingly these Xrn1-cKO mice exhibited obesity with leptin resistance, hyperglycemia, hyperphagia, and decreased energy expenditure. Obesity resulted from dysregulated communication between the central nervous system and peripheral tissues. Moreover, expression of mRNAs encoding proteins that regulate appetite and energy expenditure was dysregulated in the hypothalamus of Xrn1-cKO mice.
The study team concludes that XRN1 function in the hypothalamus is critical for maintenance of metabolic homeostasis.
The study findings were published in the peer reviewed journal: iScience.(A cell press journal)
At present obesity is a growing public health concern, with over 660 million adults worldwide designated as obese. The condition has been linked to many disorders, including cardiovascular disease, type 2 diabetes and cancer.
Dr Akiko Yanagiya, a researcher in the Cell Signal Unit at OIST, headed by Professor Dr Tadashi Yamamoto told Thailand Medical News, "Fundamentally, obesity is caused by an imbalance between food intake and energy expenditure. But we still understand very little about how appetite or metabolism is regulated by communication between the brain and parts of the body, such as the pancreas, liver and adipose tissues."
The study team created mice that were unable to produce the protein, XRN1, in a subset of neurons in the forebrain for the research.
The forebrain region includes the hypothalamus, an almond-sized structure that releases hormones into the body, helping to regulate body temperature, sleep, thirst and hunger.
Interestingly at 6-weeks-old, the study team noticed that the mice without XRN1 in the brain rapidly began to gain weight and became obese by 12 weeks of age. Fat accumulated in the mice's body, including within adipose tissue and the liver.
Upon monitoring the feeding behavior, the study team found that the mice without XRN1 ate almost twice as much each day as the control mice.
Dr Shohei Takaoka, a former PhD student from the OIST Cell Signal Unit added, "This finding was really surprising. When we first knocked out XRN1 in the brain, we didn't know exactly what we would find, but this drastic increase in appetite was very unexpected."
In order to investigate what might be causing the mice to overeat, the study team measured the blood levels of leptin-a hormone that suppresses hunger.
Strangely compared to the controls, the level of leptin in the blood was abnormally high, which would normally stop the mice from feeling hungry. But unlike the control mice, the mice without XRN1 didn't respond to the presence of leptin-a condition known as leptin resistance.
The study team also found that 5-week-old mice were resistant to insulin, a hormone that is released by beta cells in the pancreas in response to the high levels of blood glucose that occur after eating.
Importantly this type of failure in how the body responds to glucose and insulin can ultimately lead to diabetes. As the mice got older, levels of glucose and insulin in the blood rose significantly alongside the increased leptin levels.

                                                                                    Graphical Abstract
Dr Yanagiya added, “We think that the levels of glucose and insulin rose due to the lack of response to leptin. Leptin resistance meant that the mice kept eating, keeping the level of glucose in the blood high, and therefore increasing insulin in the blood."
The study team then checked whether the obesity was also driven by the mice using less energy. They placed each mouse in a special cage that measured how much oxygen the mice used to indirectly work out their metabolic rate.

In the mice aged 6 weeks, the study team did not find an overall difference in energy expenditure.
However, the team found something very surprising. The mice without XRN1 were mainly using carbohydrates as an energy source, while the control mice were able to switch between burning carbohydrate at night, when they were most active, and fat during the day, when less active.
Dr Yanagiya, "For some reason, this means that without XRN1, the mice cannot use fat as a fuel effectively. Why this occurs though, we still do not know."
Also, once the mice reached 12 weeks of age, their energy expenditure decreased compared to control mice. But, the scientists believed, this was an effect of obesity, due to the mice being less active, rather than a cause.
Dr Yanagiya added, "Overall, we think overeating due to leptin resistance was the driving cause behind why these mice became obese."
In order to further investigate how loss of XRN1 results in leptin resistance and an increased appetite, the study team looked at whether the activity of appetite-regulating genes changed within the hypothalamus.
It is already known that XRN1 plays a crucial role in gene activity, as it is involved in the last step of degrading messenger RNA (mRNA). When a gene is active, DNA is used to make a molecule of mRNA, which can then be used to build a specific protein.
Typically, cells have many ways of regulating the activity of genes, one of which is by degrading mRNA more slowly or more quickly, which results in more or less protein being made, respectively.
Interestingly in the hypothalamus, the study team found that the mRNA used to make the protein Agouti-related peptide (AgRP)-one of the most potent stimulators of appetite-was elevated in the obese mice, leading to higher amounts of AgRP protein.
Dr Yanagiya, "It's still only speculation, but we think that an increase of this protein, and abnormal activation of the neuron that produces it, might be the cause of leptin resistance in these mice. Leptin normally suppresses activity of the AgRP neuron, but if loss of XRN1 results in this neuron remaining highly active, it could override the leptin signal."
The exact mechanism of how loss of XRN1 leads to increased activation of AgRP neurons however remains unclear. XRN1 was removed only in a specific subset of neurons in the forebrain, and AgRP neurons were not among them.
Hence this suggests that another neuron that did lose XRN1 may be involved and could be signaling incorrectly to the AgRP neurons and keeping them active.
The study team hopes to collaborate with neuroscience research units, in order to pinpoint exactly how XRN1 impacts the activity of neurons in the hypothalamus to regulate appetite.
Dr Yanagiya,"Identifying which neurons and proteins in the brain are involved in regulating appetite, and fully determining how resistance to leptin is caused, could eventually lead to a targeted treatment for obesity."
For more about fighting obesity, keep on logging to Thailand Medical News.


Sep 25, 2022  1 year ago
Source: Medical News - SARS-CoV-2 Fall And Winter 2022 Variant Collections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news